Paula Peremiquel-Trillas holds a medical degree (Autonomous University of Barcelona, 2014) and a Master degree in Public Health (Pompeu Fabra University, 2017). She is specialized in Preventive Medicine and Public Health (Vall d’Hebron University Hospital, 2019). During her specialization training she did internships in the World Health Organization and in the Catalan Institute of Oncology (ICO) and she was involved in different research projects in the field of vaccinology, virology, cancer epidemiology and community health. In May 2019 she joined the Cancer Epidemiology Research Program (PREC) at ICO as epidemiologist working on the Screenwide Project while doing her PhD. Since 2020 she is also subinvestigator in the randomized clinical trial evaluating the efficacy, immunogenicity and safety of 9v-HPV vaccine versus placebo in preventing persistent oral infection in adult men (NCT04199689).